BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33099469)

  • 1. Differential Proteomic Analysis of Hepatocellular Carcinomas from
    Lambrecht C; Ferreira GB; Omella JD; Libbrecht L; DE Vos R; Derua R; Mathieu C; Overbergh L; Waelkens E; Janssens V
    Cancer Genomics Proteomics; 2020; 17(6):669-685. PubMed ID: 33099469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo.
    Lambrecht C; Libbrecht L; Sagaert X; Pauwels P; Hoorne Y; Crowther J; Louis JV; Sents W; Sablina A; Janssens V
    Oncogene; 2018 Jan; 37(4):544-552. PubMed ID: 28967903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    Chandrashekar DS; Golonka RM; Yeoh BS; Gonzalez DJ; Heikenwälder M; Gerwirtz AT; Varambally S; Vijay-Kumar M
    PLoS One; 2020; 15(6):e0234726. PubMed ID: 32559205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of
    Domènech Omella J; Cortesi EE; Verbinnen I; Remmerie M; Wu H; Cubero FJ; Roskams T; Janssens V
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.
    Ding SJ; Li Y; Tan YX; Jiang MR; Tian B; Liu YK; Shao XX; Ye SL; Wu JR; Zeng R; Wang HY; Tang ZY; Xia QC
    Mol Cell Proteomics; 2004 Jan; 3(1):73-81. PubMed ID: 14593079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic s-adenosylmethionine: relevance in human liver diseases.
    Santamaría E; Muñoz J; Fernandez-Irigoyen J; Sesma L; Mora MI; Berasain C; Lu SC; Mato JM; Prieto J; Avila MA; Corrales FJ
    J Proteome Res; 2006 Apr; 5(4):944-53. PubMed ID: 16602702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2D-DIGE Analysis of Liver Disease in Mice.
    Callebaut A; Derua R; Overbergh L; Janssens V
    Methods Mol Biol; 2023; 2596():231-244. PubMed ID: 36378443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of hepatocellular carcinoma.
    Lim SO; Park SJ; Kim W; Park SG; Kim HJ; Kim YI; Sohn TS; Noh JH; Jung G
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1031-7. PubMed ID: 11866469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
    Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
    J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
    Liu L; Huang Z; Chen J; Wang J; Wang S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):142. PubMed ID: 29986744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
    Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
    Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STK33 promotes hepatocellular carcinoma through binding to c-Myc.
    Yang T; Song B; Zhang J; Yang GS; Zhang H; Yu WF; Wu MC; Lu JH; Shen F
    Gut; 2016 Jan; 65(1):124-33. PubMed ID: 25398772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.